In Vitro P38MAPK Inhibition in Aged Astrocytes Decreases Reactive Astrocytes, Inflammation and Increases Nutritive Capacity After Oxygen-Glucose Deprivation by Revuelta Aranberri, Miren et al.
 
www.aging-us.com 6346 AGING 
INTRODUCTION 
 
Ischemic stroke, the most common type of stroke, 
represents the second main cause of death worldwide 
leading to 5.7 million of deaths per year in adulthood  
[1, 2]. Between all types of stroke, brain ischemic stroke 
represent 87% of all cases that cause neurological 
deficits such as motor impairment and inability to read 
or even aphasia [3]. 
During the last decades, ischemic stroke experimental 
models have been performed in young animals, but 
aging itself plays a critical role in the response of the 
brain to stroke [4]. Indeed, brain aging is accompanied 
by many structural and physiological alterations that 
usually involve cognitive decline [5]. Although most 
of the molecular mechanisms of brain injury are 
similar in neonatal and aged animal models [6, 7], 
certain characteristics are different, e.g., cell apoptosis 
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Proper astroglial functioning is essential for the development and survival of neurons and oligodendroglia 
under physiologic and pathological circumstances. Indeed, malfunctioning of astrocytes represents an 
important factor contributing to brain injury. However, the molecular pathways of this astroglial dysfunction 
are poorly defined. In this work we show that aging itself can drastically perturb astrocyte viability with an 
increase of inflammation, cell death and astrogliosis. Moreover, we demonstrate that oxygen glucose 
deprivation (OGD) has a higher impact on nutritive loss in aged astrocytes compared to young ones, whereas 
aged astrocytes have a higher activity of the anti-oxidant systems. P38MAPK signaling has been identified to be 
upregulated in neurons, astrocytes and microglia after ischemic stroke. By using a pharmacological p38α 
specific inhibitor (PH-797804), we show that p38MAPK pathway has an important role in aged astrocytes for 
inflammatory and oxidative stress responses with the subsequent cell death that occurs after OGD. 
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occurs a week after the injury in the immature brain 
while this period takes place only for s few hours after 
the damage in the mature brain [8]. For in vitro 
studies, the commonly used model to mimic cerebral 
ischemia is the oxygen glucose deprivation model 
(OGD) [9, 10]. 
 
Although neurons are primarily susceptible to  
injury, impairment of supporting glial cells such as 
astrocytes may contribute to secondary injury in 
neurons [11]. Proper astroglial functioning is essential 
for the development and survival of neurons and 
oligodendroglia under pathological circumstances [12]. 
Supportive properties of astrocytes are reflected in 
production of growth factors such as PDGF and IGF 
[13, 14], clearance of radicals via superoxide dismutase 
activity [15], anti-oxidant defense with glutathione 
synthesis [16], removal of glutamate from the synaptic 
cleft [17], among others. Hence, malfunctioning of 
astrocytes represents an important factor for recovery 
and repair of the brain after injury [18, 19]. The 
importance of age for differences in glial cellular 
responses after brain injury were also documented in 
microglia [20]. 
 
p38 mitogen-activated protein kinase (p38MAPK) 
pathway is a signaling pathway that can be activated in 
neurodegenerative diseases [21, 22]. p38MAPK controls 
key processes of mammalian cell homeostasis such as 
self-renewal, differentiation, proliferation and death 
[23]. Activation of p38MAPK signaling has been 
identified in neurons, astrocytes and microglia after 
ischemic stroke [24]. Moreover, p38MAPK inhibitors 
seem to be effective reducing infarct volume after stroke 
[21, 25, 26], but the cell type being involved in 
p38MAPK dependent injury in the brain after stroke 
remains to be elucidated, as well as the effect of 
p38MAPK in aged cells after stroke. 
 
Therefore, our aim was to investigate the effect of OGD 
in young and aged primary rat astrocyte cultures and to 
analyze the expression and effect of p38MAPK in these 
cultures. For this, we cultured young and aged 
astrocytes with PH-797804, MAPK14 (p38α) inhibitor, 
the most abundant isoform of p38MAPK in the brain, to 
define changes in supporting and protective properties 
of astrocytes that can be critical for survival of brain 
cells. 
 




All animal experiments were performed in accordance to 
German and Spanish animal welfare law with the 
permission of the Animal Welfare Committee of Berlin 
(LAGeSo T-0124/08) and the permission of Biodonostia 
Institute Animal Care Committee. Wistar rats (FEM, 
Charité) were housed in specific pathogen-free barrier 
areas of the Hospital Charité Institute in Berlin while the 
C57B/6 (Jackson Laboratory) mice were housed in the 
Biodonostia Institute. Mice were maintained under a 12-
hour light/12 hour dark cycle at 22° C with controlled 
humidity and with food and water provided ad libitum 
and handled in compliance with the animal research 
regulations specified in the European Communities 
Directive [2010/63/EU]. 
 
Astrocyte primary cultures 
 
Primary astrocytes cell culture was prepared from 
neonatal Wistar rats during the first postnatal day of life. 
After dissection and careful removal of the meninges, 
both hemispheres were dissociated mechanically [13]. 
Cells were resuspended in Dulbecco’s Modified Eagle 
Medium (DMEM, Invitrogen, USA) supplemented with 
20% fetal calf serum, 1% penicillin/streptavidin and 
subsequently seeded in T75 flasks coated with poly-L-
lysine (200 μg/ml, Sigma-Aldrich) and grown in a 
humidified incubator maintained at 37° C under >90% 
humidity and 5% CO2. Medium was changed every 2-3 
days. After 7-10 days, the cultures were shaken 
overnight to minimize oligodendroglia and microglia 
contamination. For purification, the remaining astrocyte 
monolayers were trypsinized and replated. Cells were 
seeded in 12-well plates containing approximately 
15,000 cells for immunocytochemistry and ATP analysis; 
in 6-well plates containing approximately 500,000 cells 
for quantitative RT-PCR and 106 cells/well for western 
blot analysis. 
 
Oxygen-glucose deprivation (OGD) 
 
The culture medium was replaced with deoxygenated 
and glucose-free DMEM. Then cells were transferred to 
a humidified anaerobic chamber filled with a gas 
mixture of 5% CO2 and 95% N2 at 37° C. Throughout 
the OGD period of 4 hours, an atmosphere of <0.5% 
oxygen was maintained. After the OGD period, the 
media was quickly replaced with glucose-containing 
(1g/L) DMEM. Some samples were collected and others 
were reintroduced into normoxic conditions for 20 
hours of reperfusion/recovery. Control cells in DMEM 
containing 4.5g/L glucose were always kept in a 
normoxic incubator. 
 
OGD was performed 24h after cells were seeded (1DIV) 
or 4 weeks after (30DIV) to simulate an in vitro model 
of aging astrocytes [20]. The medium of the aged cells 
was changed every 2-3 days. For assays with 
P38MAPK inhibitor, astrocytes were treated with 2 µM 
PH-797804 (Selleckchem) added to the medium when 
 
www.aging-us.com 6348 AGING 
seeded and included in every medium change. Control 
group were astrocytes with and without treatment in the 




ATP concentration was detected with the use of the 
Luminescent ATP Detection Assay Kit (Abcam, 
Cambridge, UK) according to the manufactures guide 
lines. Briefly, cultured astrocytes were incubated with a 
detergent on a shaker for 5 minutes. After total cell 
lyses, substrate for luminescence detection was added 
and incubated for 5 minutes. Luminescence was 





After mice perfusion, coronal serial sections of 50 μm 
were collected via SM2010 R Sliding Microtome 
(Leica) from young (2 months-old) and aged (2 years 
old) C57BL/6 mice and selected brain sections were 
blocked with 10% donkey serum and 0.1% Triton  
X-100 in phosphate-buffered saline and incubated with 
anti-P-p38MAPK (1:200; rabbit, Cell Signalling) and 
anti-GFAP conjugated with Alexa Fluor 488 (1:500; 
mouse, Sigma) overnight at 4° C. Nuclei were stained 
with DAPI staining (Sigma). Images were acquired 




After removal of the medium, cells seeded on 
coverslips were fixed with 4% paraformaldehyde for 
15 min for immunocytochemical procedure. The 
samples were pre-incubated with a blocking solution 
(10% goat serum and 0.1% Triton X-100 in phosphate-
buffered saline) for 30 min and then incubated with a 
mouse monoclonal anti-GFAP (1:400, Sigma, USA) 
for 2 hrs at room temperature, followed by incubation 
with rabbit anti cleaved caspase-3 (Asp175) (1:400, 
cell signaling) at 4° C overnight. After washes, cells 
were incubated with the respective secondary 
antibodies. Finally, after three washings, the sections 
were mounted with Vectashield HardSet Mounting 
Medium with DAPI (Sigma). Images were acquired 




RNA extraction was performed with acidic 
phenol/chloroform (peq-GOLDRNApure, PEQLAB 
Biotechnologie, Erlangen, Germany) following the 
manufacturer protocol, and 2 µg of RNA were reverse 
transcribed. Primers were used for insulin-like growth 
factors (Igf), neuronal growth factor (Ngf), glial 
fibrillary acidic protein (Gfap), superoxide dismutase 2 
(Sod2), glutamine synthetase (Gs), glutamate aspartate 
transporter (Slc1a3), catalytic subunit of glutamate 
cysteine ligase (Gclc), to analyse the cDNA and Hprt 
was used as housekeeping gene (see Table 1). The 
expressions of target genes were analyzed with the 
StepOnePlusTM qPCR System (Applied Biosystems, 
Life Technologies, Carlsbad, CA) according to the 
2−ΔΔCT method [27]. 
 
Western blot analysis 
 
Immunoblots were performed following standard 
procedures. Equal amounts of protein (20 µg) were 
separated on 15% SDS polyacrylamide gels and 
blotted onto nitrocellulose membranes (BioRad). 
Primary antibodies were P-p38MAPK (1:200; Cell 
Signalling), total GFAP (1:100, Santa Cruz), TNFα 
(1:200, PromoCell), cleaved caspase 3 (1:1000, Cell 
Signaling) and α-ACTININ (1:2000, Sigma), followed 
by appropriate secondary antibodies conjugated  
with horseradish peroxidase (DAKO). Detection  





All data are presented as mean ± standard error of the 
mean (SEM). After the assessment of normality with 
Kolmogorov Smirnov test (KS), t student test was 
performed to compare the differences between the 
control and the OGD group. Group differences were 
studied by one-way ANOVA with Bonferroni-Dunn 
correction. Two-sided P<0.05 was considered 
statistically significant. The statistical analysis of data 
was performed using GraphPad prism 5 software 




Aged astrocytes show increased GFAP reactivity, 
inflammation, and cell death as well as lower 
nutritive and anti-oxidative capacity 
 
We determined the GFAP reactivity in the cortex and 
dentate gyrus (DG) of the hippocampus in young (2 
month-old) and aged (≥ 2 year-old) C57BL/6 mice. 
Immunofluorescence showed an increased expression of 
GFAP with aging (Figure 1A). To verify the age 
dependent increase of GFAP in astrocytes, we cultured 
rat neonatal astrocytes and simulated an in vitro model 
of aging (30DIV). Increased GFAP expression in vivo 
was confirmed in primary astrocytes in vitro. Aged 
astrocytes showed increased GFAP expression (0.6 ± 
0.13 vs 1.3 ± 0.15 ratio vs DAPI) compared to younger 
cells (1DIV) (Figure 1B). 
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Table 1. Primer used in qPCR. 
Gene Forward primer Reverse primer GenBank ID 
Cntf AACCTTGACTCAGTGGATGGTGTA AAGCCTGGAGGTTCTCTTGGA NM_013166.1 
Gclc GGAGGACAACATGAGGAAACG GCTCTGGCAGTGTGAATCCA NM_012815.2 
Gfap TCTGGACCAGCTTACTACCAACAG TGGTTTCATCTTGGAGCTTCTG NM_017009.2 
Igf-1 CGGACCAGAGACCCTTTGC GCCTGTGGGCTTGTTGAAGT NM_001082479.1 
Ngf ACCCAAGCTCACCTCAGTGTCT GACATTACGCTATGCACCTCAGAGT NM_001277055.1  
Slc1a3 CCCTGCCCATCACTTTCAAG GCGGTCCCATCCATGTTAAT NM_001289942.1 
Sod2 GACCTACGTGAACAATCTGAACGT AGGCTGAAGAGCAACCTGAGTT NM_017051.2 
Hprt GGAAAGAACGTCTTGATTGTTGAA CCAACACTTCGAGAGGTCCTTTT NM_012583.2 
 
Mitochondria generate the majority most of cellular 
ATP supply, which is essential for energy consuming 
cell processes [28]. To investigate the impact of aging 
on cellular energy supply we measured the ATP 
concentration in 30DIV (old) astrocytes and 1DIV 
(young). As a result, ATP luminescence was reduced in 
aged astrocytes to almost half of the level found in 
young cells (P<0.01) (Figure 1C). 
 
Regulation of glutamate homeostasis is one of the major 
functions of astrocytes in the brain. The enzyme 
glutamine synthetase (GS) is needed to transform 
glutamate intracellularly into glutamine, which is stored 
in vesicles [29]. In order to determine the impact of 
aging on glutamate homeostasis, we analyzed gene 
expression of Gs and of Slc1a3 (EAAT1 or GLAST) 
representing a glutamate transporter molecule highly 
abundant in these cells [30]. qPCR analysis revealed 
that expression of Gs and Slc1a3 is drastically reduced 
in aged astrocytes (Figure 1D, 1E). These results 
demonstrate that aging alters the expression of genes 
relevant for glutamate homeostasis in astrocytes. 
 
The astrocytes anti-oxidant defense system is regulated 
via the Nrf2-pathway [31], which orchestrates the 
expression of its target genes including glutathione 
synthetase [32]. To define the impact of aging on anti-
oxidant gene expression in astrocytes, we determined 
levels of Sod2 and of catalytic subunit of glutamate 
cysteine ligase (Gclc) gene expression. The expression 
levels of Sod2 and Gclc were significantly decreased in 
aged cultures indicating impairment of the anti-oxidant 
system in old astrocytes (Figure 1F, 1G). 
 
To further characterize the mechanism of cell alterations 
caused by aging, we determined the expression  
of various growth factors, inflammatory response 
related genes, and performed caspase-3a (CASP3A) 
immunofluorescence staining for apoptosis. Aged 
astrocytes displayed a reduction of igf and an increase 
of il6 (Figure 1H, 1I) gene expression. The numbers of 
CASP3A positive astrocytes in aged cultures were 
increased as compared to young cultures (2.9 ± 0.5 % 
vs. 3.9 ± 0.3 %, number of CASP3A+ cells expressed as 
a percentage of all DAPI cells (p<0.05) (Figure 1J). 
Western blot analysis corroborated the results of 
elevated GFAP and CASP3A expression in old cells 
(Figure 1K). 
 
Loss of function in response to OGD is more 
pronounced in aged than in young astrocytes: role of 
cellular ATP levels, nutritive properties, and anti-
oxidative capacity 
 
To investigate the impact of OGD in young and aged 
astrocytes in vitro, we performed 4h of OGD (Figure 
2A), and determined GFAP immunoreactivity in young 
and aged astrocytes. Immunofluorescence showed a 
significant OGD-induced increase of GFAP expression 
in both groups after OGD, which was even more 
pronounced in aged astrocytes (Figure 2B). The staining 
of GFAP was elevated exclusively in aged astrocytes 
after reperfusion/recovery. 
 
We also determined the effect of OGD on cellular 
energy supply in young and aged astrocytes by ATP 
assay (Figure 2C). Reduction of ATP dependent energy 
after OGD in young astrocytes was restored back to 
control levels after 20 hours of reperfusion/recovery. 
Notably, in aged astrocytes, the OGD-induced decline 
of energy supply was still largely reduced after the 
phase of recovery (Figure 2C). This highlights that 
OGD hits aged astrocytic energy supply in a persistent 
way, and that the capacity of recovery and cellular 
repair is strongly impaired in old as compared to young 
astrocytes. 
 
We also characterized the effect of OGD on glutamate 
uptake, anti-oxidative capacity, growth factor regulation, 
inflammatory response and cell death in young and  
aged astrocytes. Aging caused a significant upregulation 
of Gs, Slc1a3, Sod2, Gclc immediately after OGD 
indicating astroglial activation and induction of the anti-
oxidant defense system compared to young astrocytes 
(Figure 2D–2G). OGD increased Igf-1 expression  
only in aged astrocytes but its expression was
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Figure 1. Aged astrocytes have increased reactivity, inflammation and cell death as well as loss of nutritive and anti-
oxidative capacity. (A) Representative immunofluorescence for GFAP (red) in cortex and DG of young (2 month-old) and aged (over 24 
month-old) C57BL/6J mice (n=2). (B) Representative immunofluorescence and the quantification for GFAP positive cells in 1DIV (young) and 
30DIV (old) primary astrocytes cell culture derived from neonatal Wistar (n=6). (C) ATP luminescence levels of young and old primary 
astrocytes cultures (ratio compared to the young group) (n=4). (D–I) Expression of gs, slc1a3, sod2, gclc, igf-1 and il-6 in young and old 
primary astrocytes cultures (n=6). (J) Representative immunofluorescence of CASPASE 3A and co-staining of CASPASE 3A (red) with GFAP 
(green) together with DAPI (blue). Quantification for CASPASE 3A positive cells and in 1DIV (young) and 30DIV (old) primary astrocytes cell 
culture derived from P1 Wistar rat pups (n=6). (K) Protein expression of CASPASE 3A and GFAP in 1DIV (young) and 30DIV (old) primary 
astrocytes cell culture. Results are expressed as the mean ± SEM. Asterisks denote the significance levels when compared to the control 
group (***p<0.001, **p<0.01 and *p<0.05 versus controls, t-test). 
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Figure 2. OGD has a higher impact in nutritive loss in aged compared to young astrocytes, whereas aged astrocytes have 
better anti-oxidant systems. (A) Representative optical microphotograph of young and old primary astrocytes derived from neonatal 
Wistar rats after 4h of OGD and after 20h of recovery compared to the control group. (B) Representative immunofluorescence and 
quantification of GFAP positive cells (green) in 1DIV (young) and 30DIV (old) primary astrocyte cell cultures after 4h of OGD and after 20h of 
recovery compared to the age matched control groups without OGD (n=6). (C) ATP luminescence levels in young and old primary astrocyte 
cultures after 4h of OGD and after 20h of recovery compared to control groups (n=4). (D–H) Expression of gs, slc1a3, sod2, gclc and igf-1 in 
young and old astrocytes after 4h of OGD and after 20h of recovery compared to controls (n=6). (I) Protein expression of TNFα in young and 
old cultured astrocytes after 4h of OGD compared to controls. (J) Representative immunofluorescence and the quantification for CASPASE 3A 
positive cells in 1DIV (young) and 30DIV (old) astrocytes cell culture derived from neonatal Wistar after 4h of OGD and after 20h of recovery 
compared to the control group (n=6). Results are expressed as the mean ± SEM. Asterisks denote the significance levels when compared to 
the control group (***p<0.001, **p<0.01 and *p<0.05 versus controls, t-test). 
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downregulated after reperfusion/recovery in both groups 
(Figure 2H). Finally, there was a significant upregulation 
of TNFα and CASPASE3A after OGD in young and 
aged astrocytes (Figure 2I, 2J). 
 
p38MAPK activity increases in aged astrocytes and 
its expression is reduced with PH-797804 
 
p38MAPK activity (P-p38MAPK) and its isoforms are 
increased in different cell types in aged mouse brain 
[33]. Indeed, p38MAPK is one of the most important 
kinases in inflammatory signaling and its activation  
has been identified in many neurodegenerative diseases 
[21]. We first studied the expression of p38MAPK  
in the cortex and DG of hippocampus in young  
(2 month-old) and aged (≥ 2 year-old) C57BL/6J  
mice. Immunofluorescence showed that P-p38MAPK 
expression was increased in over 2 year-old animals 
(Figure 3A), supporting previous studies in the DG [33]. 
Next, we measured P-p38MAPK in cultured young and 
aged astrocytes and found that P-p38MAPK expression 
was strongly increased in aged compared to young 
astrocytes (Figure 3B). Finally, the addition of PH-
797804 to aged astrocyte cultures lowered levels of P-
P38MAPK and Mapk14 (p38alpha) gene expression by 
50% after OGD and after reperfusion in comparison to 
control cells (Figure 3C, 3D). 
 
Pharmacological inhibition of p38α in aged 
astrocytes prevents astroglial reactivity, 
inflammatory response and anti-oxidant defense 
system activation after OGD 
 
Finally, we aimed to clarify whether p38α inhibition 
could have beneficial effects in aged astrocytes after 4h 




Figure 3. p38MAPK activity increases in aged astrocytes and its expression is reduced with PH-797804. (A) Representative 
immunofluorescence and quantification for phosphorylated p38MAPK (P-p38MAPK) (green) together with DAPI (blue) and GFAP (red) in the 
cortex and in the DG of young (2 month-old) and aged (over 24 month-old) C57BL/6J mice (n=2). (B) Immunoblot of P-p38MAPK in 1DIV 
(young) and 30DIV (old) primary astrocyte cultures derived from Wistar rat brains. (C) Immunoblot of P-p38MAPK in old astrocyte cultures 
with and without PH-797804 treatment. (D) MAPK14 gene expression in old astrocyte cultures treated with PH-797804 at different time 
points in comparison to the control groups (without treatment) (n=6). Results are expressed as the mean ± SEM. Asterisks denote the 
significance levels when compared to the control group (***p<0.001, **p<0.01 and *p<0.05 versus controls, t-test). 
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Figure 4. Pharmacological inhibition of p38α in aged astrocytes prevents from astrocytes reactivity, inflammatory response 
and anti-oxidant defense system activation after OGD. (A) Representative optical microphotograph of old primary astrocytes derived 
from neonatal Wistar after 4h of OGD and treated with PH-797804. (B) MAPK14 gene expression in old astrocyte cultures after 4h of OGD 
(white), after 4h of OGD with PH-797804 treatment (blue column) in comparison to controls treated with PH-797804 (black) (n=6).  
(C) Immunoblot of GFAP, TNFα and P-p38MAPK in old primary astrocytes cell culture derived from neonatal Wistar in normoxia and after 4h 
of OGD and with or without the treatment, PH-797804. (D) Representative quantification of GFAP positive cells in old astrocyte cultures 
derived after 4h of OGD, after 4h of OGD with PH-797804 treatment, and in control cultures treated with PH-797804 (n=6). (E–K) Expression 
of gs, slc1a3, sod2, gclc, ngf, igf-1 and il-6 in old astrocyte after 4h of OGD, after 4h of OGD with PH-797804 treatment, in controls treated 
with PH-797804 (n=6). Results are expressed as the mean ± SEM. Asterisks denote the significance levels when compared to the control 
group (***p<0.001, **p<0.01 and *p<0.05 versus controls, t-test). 
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(p38MAPK alpha) expression was increased after  
OGD in aged astrocyte compared to the control group 
(Figure 4B). Analysis of TNFα, GFAP and P-p38MAPK 
protein expression after OGD revealed that there was a 
reduction of all these proteins in aged astrocytes treated 
with PH-797804 after OGD (Figure 4C). 
 
We corroborated astroglial inhibition with GFAP 
immunofluorescence in which astrocytes treated with 
the p38α inhibitor expressed lower levels of astrogliosis 
compared to the untreated OGD group directly after the 
injury and also after recovery (Figure 4D). 
 
To further characterize the effect of pharmacological 
inhibition of p38α in aged astrocytes after OGD and 
after recovery, we characterize the effects on glutamate 
uptake, anti-oxidative capacity and growth factor 
response. Gene expression of selected genes of those 
processes, Gs, Slc1a3, Gclc, Sod, Ngf and Igf-1 was 
reduced in p38α inhibited astrocytes treated with PH-
797804 immediately after OGD and also after recovery 
(Figure 4E–4J). Hence, pharmacological inhibition of 
p38α attenuates the oxidative challenge in aged 
astrocytes caused by OGD. 
 
Finally, we analyzed the inflammatory response of 
astrocytes with PH-797804 treatment after OGD. The 
increase in aged astrocytes after 20h of recovery was 





In the central nervous system (CNS), astrocytes are the 
central cell type to support neuronal survival under 
pathological circumstances [34]. Indeed, as astrocytes, 
but not neurons, shift in gene expression patterns with 
aging, it has been proposed that they may be a better 
indicator of age in the brain than neurons [35]. Our in 
vitro results showed that aging increases the reactivity 
and inflammatory response of primary rat astrocytes. 
Previous reports show that astrocytes show age-
dependent inflammatory responses [36] and increased 
GFAP expression [37, 38], which has been characterized 
as a hallmark of brain aging [5]. Moreover, our results 
indicate that the anti-oxidant and cellular energy system 
of in vitro aged astrocytes is decreased compared to the 
young ones, hence facilitating increased cell death. A 
proper cellular anti-oxidative capacity is necessary for 
oxidative stress protection, and a decline in ATP levels 
may contribute to neurodegeneration as it is related to 
regulating neuronal activity through synaptic inhibition 
[39]. The challenge through sublethal energy failure in 
our in vitro experiments may therefore lead or contribute 
to exhaustion of the anti-oxidant system. Furthermore, 
we found decreased Gs and Scl1a3 expression in aged 
astrocytes, hence pointing towards perturbed glutamate 
homeostasis as a potential trigger of cellular toxicity [29]. 
As a consequence, it can be assumed that protection of 
neurons via the anti-oxidant system of astrocytes is 
impaired by aging [40]. As a nutritive factor, IGF1 is 
considered to be essential for neuronal survival and 
development [41]. Moreover, previous studies have 
found that a lack of IGF1 reduces brain size with a 
cellular loss in the neuronal population and myelination 
deficits [42], but little attention has been paid to 
astrocytes as a source of IGF1, specifically. 
Consequently, the Igf1 reduction found in our aged 
astrocytes may represent an injurious event to brain cells 
that were previously hit by energy failure. Altogether, 
the complex changes including inflammatory response, 
astrogliosis, energy failure, decreased anti-oxidative 
capacity and elevated caspase-3 activity may contribute 
to an increased “in vitro” aged astrocyte cell death. 
 
As mentioned, aging alone increases astroglial reactivity 
[43], which is an observation also supported by our 
results, but this glial response is exaggerated following 
ischemia-stroke in the brain, hence accelerating glial scar 
formation [4]. We found that responses of energy failure 
and inflammation were exaggerated following 4 hours of 
OGD in our in vitro aged astrocytes compared to the 
young astrocytes, and that these alterations were 
maintained during the phase of recovery. However, 
although aged astrocytes present decreased anti-oxidative 
capacity, after OGD we observed an upregulation of anti-
oxidant system defense, growth factor release and 
glutamate uptake. Cellular defense in the brain involve 
endogenous protective enzymes such as SOD and 
glutathione (GSH), which are produced by astrocytes to 
protect neurons against oxidative stress. In previous 
studies it has been demonstrated that the cellular anti-
oxidant system and GSH release is upregulated in 
astrocytes as a response to pathological circumstances, 
possibly as a defense mechanism to prevent cell 
apoptosis [44]. Hence, the increase of cellular anti-
oxidant defense system, Gs and Slc1a3 expression and 
growth factor expression may represent a cellular attempt 
of compensation in aged astrocytes in response to 
astrogliosis, inflammation and CASPASE 3 activation 
induced by OGD. 
 
Our results show enhanced p38MAPK activity with 
aging in astrocytes, both in astrocyte cultures in vitro 
and in the cortex and dentate gyrus (hippocampus) in 
vivo, which complement previous results obtained in 
neurogenic niches (SVZ) in vivo and in neurospheres 
derived from aged mice [45]. Elevated p38MAPK 
activity has also been identified in neurodegenerative 
disease and in response to brain injury such as  
brain stroke [46], and its pharmacological inhibition 
ameliorated symptoms of neurodegenerative diseases 
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and was protective against ischemia [21, 25]. We show 
that Mapk14 expression was increased in aged 
astrocytes directly after OGD and that pharmacological 
p38α inhibition in aged astrocytes after OGD restored 
Mapk14 expression back to control levels. Moreover, 
the P38MAPK pathway has been described as 
inflammatory mediator in the CNS [33]. In our results, 
the inactivation of p38α in aged astrocyte cultures 
treated by PH-797804 attenuated astroglial activation 
and inflammation that occur after OGD. We also found 
that PH-797804 treatment in aged astrocytes can 
prevent OGD-induced changes of growth factors igf and 
ngf, of the free radical clearance factors sod2 and gclc, 
and of the glutamate metabolism system gs that were 
increased after OGD. The impaired production of these 
factors has previously been reported to alter the 
supportive properties of astrocyte [13, 47]. 
 
In summary, our experiments with OGD highlight an 
impairment of various astroglial functions that are 
important for the support of neuronal development and 
for protection of the brain both in young and aged 
astrocytes cell culture. Inhibition of p38α in aged in 
vitro astrocytes may provide effective protection 
reducing astrogliosis and inflammation that occurs in 
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